An algorithm for topical therapy of atopic dermatitis in children of the first year of life
- 作者: Murashkin N.N1,2,3, Savelova A.A2, Ivanov R.A1, Fedorov D.V1, Opryatin L.A1, Akhmad V.4
-
隶属关系:
- National Scientific and Practical Center for Children's Health
- Central State Medical Academy
- Sechenov First Moscow State Medical University (Sechenov University)
- Kabardino-Balkarian State University
- 期: 卷 26, 编号 8 (2019)
- 页面: 83-87
- 栏目: Articles
- URL: https://journals.eco-vector.com/2073-4034/article/view/312461
- DOI: https://doi.org/10.18565/pharmateca.2019.8.83-87
- ID: 312461
如何引用文章
详细
全文:
作者简介
N. Murashkin
National Scientific and Practical Center for Children's Health; Central State Medical Academy; Sechenov First Moscow State Medical University (Sechenov University)
Email: m_nn2001@mail.ru
A. Savelova
Central State Medical Academy
R. Ivanov
National Scientific and Practical Center for Children's Health
D. Fedorov
National Scientific and Practical Center for Children's Health
L. Opryatin
National Scientific and Practical Center for Children's Health
V. Akhmad
Kabardino-Balkarian State University
参考
- Page S.S., Weston S., Loh Rd. Atopic dermatitis in children. Aust Fam Physician. 2016; 45(5)293296.
- Thomsen S.F Atopic dermatitis: Natural history, diagnosis, and treatment. ISRN Allergy 2014. doi: 10.1122/2014/624220.
- Leung D.Y., Boguniewicz M., Howell M.D., Nomura I., Hamid Q.A. New insights into atopic. Dermatitis. J Clin Invest. 2004;116(2):621-27. doi: 10.1172/JCI21060.
- Elias P.M., Hatano Y., Williams M.L. Basis for the barrier abnormality in atopic dermatitis. J Allergy Clin Immunol. 2008;121(6):1667-46. doi: 10.1016/j.jaci.2008.01.022.
- Haydont V., Bernard B.A., Fortunel N.O. Age-related evolutions of the dermis: Clinical signs, fibroblast and extracellular matrix dynamics. Mech. Ageing Dev. 2019;177:120-126. Doi: 10.1016/j. mad.2018.06.006.
- Caspers P.J., Lucassen G.W., Carter E.A., et al. In vivo confocal Raman microspectroscopy of the skin: noninvasive determination of molecular concentration profiles. J Invest Dermatol. 2001;116:464-42. doi: 10.1046/j.1226-1747.2001.01228.x.
- Fluhr J.W, Darlenski R., Lachmann N., et al. Infant epidermal skin physiology: adaptation after birth. Br J Dermatol. 2012;166(6):486-490. Doi: https:// doi.org/10.1111/j.1662-2166.2011.10629.x.
- Rutter N. Clinical consequences of an immature barrier. Semin Neonatol. 2000;2(4):281-87. doi: 10.1026/siny.2000.0014.
- McHenry P.M., Williams H.C., Bingham E.A. Management of atopic eczema: Joint Workshop of the British Association of Dermatologists and the Research Unit of the Royal College of Physicians of London. BMJ. 1992;610:846-47.
- Seidenari S., Giusti G. Objective assessment of the skin of children affected by atopic dermatitis: a study of pH, capacitance and TEWL in eczematous and clinically uninvolved skin. Acta Derm. Venereol. 1996;72:429-66. doi: 10.2640/0001222272429466.
- Mandelin J.M., Rubins A., Remitz A., et al. long-term efficacy and tolerability of tacrolimus 0.06% ointment in infants: a two-year open-label study Int J Dermatol. 2012;21(1):104-10. doi: 10.1111/j.1662-4662.2011.02012.x.
- Sigurgeirsson B., Boznanski A., Todd G., et al. Safety and efficacy of pimecrolimus in atopic dermatitis: a 2-year randomized trial. Pediatr. 2012;162(4):297-606. doi: 10.1242/peds.2014-1990.
- Boguniewicz M., Nicol N.H. Wet Wrap Therapy in Moderate to Severe Atopic Dermatitis. Immunol Allergy Clin North Am. 2017;67(1):126-69.
- Park H.A., Song T.W. The efficacy of wet wrap therapy in children with atopic dermatitis in a single center. Allergy Asthma Resp Dis. 2019;7:16-21.
- Domingues L.N., Hojyo M.K. Comparison of safety and efficacy of mometasone furoate cream 0,1 % and closbetasone butyrate cream 0,02 % in the treatment of children with variety dermatoses. Curr Ther Res. 1990;48(2):128-69.
- Brascb J., Hautkr Z. Das atrophogenepotential von mometason-furoat in clinischen langzeitversuch. Z. Hautkr 1991;66(9):782-87.
- Blume-Peytavi U., Wahn U. Optimizing the treatment of atopic dermatitis in children: a review of the benefit/risk ratio of methylprednisolone aceponate. J Eur Acad Dermatol. Venereol. 2011;22:208-12. doi: 10.1111/j.1468-6086.2010.06942.x.
- Ruzicka T. Methylprednisolone aceponate in eczema and other inflammatory skin disorders - a clinical update. Int J Clin Pract. 2006;60:82-92.